|
Pronunciation |
|
(oks
TRYE fi
lin) |
|
|
Generic
Available |
|
Yes |
|
|
Synonyms |
|
Choline Theophyllinate |
|
|
Pharmacological Index |
|
Theophylline Derivative |
|
|
Use |
|
Bronchodilator in symptomatic treatment of asthma and reversible
bronchospasm |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
Uncommon with theophylline levels <20 mcg/mL
Cardiovascular: Tachycardia
Central nervous system: Nervousness, restlessness
Gastrointestinal: Nausea, vomiting
<1%:
Central nervous system: Insomnia, irritability, seizures
Dermatologic: Skin rash
Gastrointestinal: Gastric irritation
Neuromuscular & skeletal: Tremor
Miscellaneous: Allergic reactions |
|
|
Usual Dosage |
|
Oral:
Children 9-16 years and Adult smokers: 4.7 mg/kg/dose every 6 hours
Adults: 4.7 mg/kg every 8 hours; sustained release: administer every 12 hours
|
|
|
Dietary
Considerations |
|
Should be administered with water 1 hour before or 2 hours after
meals |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
Do not prescribe any erythromycin product to patients taking theophylline
products. Erythromycin will delay the normal metabolic inactivation of
theophyllines leading to increased blood levels; this has resulted in nausea,
vomiting and CNS restlessness |
|
|
Patient
Information |
|
Oral preparations should be taken with a full glass of water; avoid drinking
or eating large quantities of caffeine-containing beverages or food; take at
regular intervals; take with food if GI upset occurs; notify physician if
nausea, vomiting, insomnia, nervousness, irritability, palpitations, seizures
occur; do not change from one brand to another without consulting physician and
pharmacist; do not change doses without consulting your
physician |
|
|
Nursing
Implications |
|
Administer oral administration around-the-clock rather than 4 times/day, 3
times/day, etc, (ie, 12-6-12-6, not 9-1-5-9) to promote less variation in peak
and trough serum levels; do not crush sustained release drug products; encourage
patient to drink adequate fluids (2 L/day) to decrease mucous viscosity in
airways
Monitor heart rate, vital signs, serum concentrations, CNS effects (insomnia,
irritability); respiratory rate (COPD patients often have resting controlled
respiratory rates in the low 20s) |
|
|
Dosage Forms |
|
Elixir: 100 mg/5 mL (5 mL, 10 mL, 473 mL)
Syrup: 50 mg/5 mL (473 mL)
Tablet: 100 mg, 200 mg
Sustained release: 400 mg, 600 mg
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|